But heres the rub: putrescine and cadaverine both interfere with MAO activity and therefore behave as mild MAO-inhibitors
According to the same survey, Awareness of GLP-1 drugs has increased in the past year, with about one-third (32%) of adults now saying they have heard a lot about these drugs, up from 19% in July 2023. Fifty-four percent of people who took a GLP drug said it was difficult to afford and it is often reported that, although doctors recommend staying on these drugs for a lifetime, many abandon them after a year
Dr Breeda Neville, Consultant in Public Health Medicine, HSE NCCP, said: Skin cancer is one of the fastest growing cancers in Ireland
Risks and Considerations, While compounded medications can offer some benefits, they also come with significant risks: Lack of Regulation and Testing : Unlike brand-name medications, compounded drugs are not subject to the same testing and FDA approval process
IMO not worth the risk